Anteris thanks Dr. Vinnie Bapat @bapat_savrtavr for his wonderful presentation of DurAVR THV and early results from the #DurAVR First-in-Human study. Excited for Australian physicians to see these data at #ANZET#CSANZ22.
DurAVR THV – developed in Australia!
Expert cardiac surgeon and #Anteristech Global Advisory Board Member Michael Reardon, MD highlighted durability, which is a combination of valve design and tissue science, as a key issue facing aortic stenosis patients & physicians at #CSANZ22 today. $avr#LastsLongerWorksBetter